Furthermore, studies evaluating PD1 and PD-L1 expression in the peripheral blood of ccRCC patients found that levels of sPD1 and sPD-L1 were lower in cancer patients compared to healthy controls, but higher in metastatic patients compared to non-metastatic ones [24]. This evidence concerns the gene CD274 and cancer.